A New Buffer for Gallium-68 Labeling Suitable for Use in Nuclear Medicine; Triethanolamine (TEA)

CONCLUSION: We present an alternative procedure for labeling PSMA-HBED-CC and DOTATATE peptides with [68GaCl3] to obtain high radioactive doses of final radiopharmaceutical products used in nuclear medicine clinical applications. We have provided a quality-controlled final product that can be used in clinical diagnostic procedures. With the use of an alternative buffer, these methods could be adapted to semi-automatic or automated modules routinely used in nuclear medicine laboratories to label [68Ga]-based radiopharmaceuticals.PMID:37218205 | DOI:10.2174/1874471016666230522100024
Source: Current Radiopharmaceuticals - Category: Radiology Authors: Source Type: research